Standard BioTools jumps on sale of SomaLogic to Illumina
Source: SeekingAlpha
2025-06-23 07:20:44 ET
More on Illumina, Standard BioTools
- Standard BioTools: Too Early To Determine The Fate Of This Turnaround
- Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)
- Illumina: Multiple Headwinds Point To Limited Upside In 2025
- Insider trades: Apple, Disney among notable names this week
- Illumina stock rises after executives disclose stock purchase
Read the full article on Seeking Alpha
For further details see:
Standard BioTools jumps on sale of SomaLogic to Illumina
Standard BioTools Inc.
NASDAQ: LAB
LAB Trading
2.12% G/L:
$0.9534 Last:
723,321 Volume:
$0.9326 Open:
LAB Latest News
February 24, 2026 04:10:00 pm
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
LAB Stock Data
$476,861,113
295,500,064
21.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
